date,title,source
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-17-18,MIT researchers among winners of prestigious Breakthrough Prize,American City Business Journals
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-18-18,Biogen to Present Data from Alzheimers Disease Portfolio at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Meeting,GlobeNewswire
Oct-19-18,Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?,Zacks
Oct-19-18,Alkermes Boasts Strong Portfolio and Impressive Pipeline,Zacks
Oct-19-18,"Stocks making the biggest move premarket: PG, HON, F, VFC, HOG AMZN & more",CNBC
Oct-22-18,Biogen earnings: Its all about upcoming Alzheimers disease results,MarketWatch
Oct-22-18,Biogen Q3 Earnings Outlook,Benzinga
Oct-22-18,"Analysts wary of Biogen's strategy as earnings, Alzheimer's data loom",American City Business Journals
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,Biogen on Deck as Biotechs Face Make-or-Break Earnings Season,Bloomberg
